Brain, Vol. 124, No. 6, 1091-1099,
June 2001
© 2001 Oxford University Press
Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A
1 Service de Biochimie BAP-HP, 2 Laboratoire de Neuropathologie, Groupe Hospitalier Pitié-Salpêtrière, 3 Fédération de Neurologie and INSERM U546, Groupe Hospitalier and Faculté de Médecine Pitié-Salpêtrière and 4 Département de Néphrologie, Hôpital Necker-Enfants Malades, Paris, France and 5 Department of Applied Physiology, University of Ulm, Germany
Correspondence to:
Professor B. Fontaine, INSERM U546, Faculté de Médecine Pitié-Salpêtrière, 105 Bd Hôpital, 75013 Paris, France E-mail: bertrand.fontaine{at}psl.ap-hop-paris.fr
Hypokalaemic periodic paralysis (hypoPP) is an autosomal dominant muscle disorder characterized by episodic attacks of muscle weakness associated with a decrease in blood potassium levels. Mutations in the gene encoding the skeletal muscle voltage-gated calcium channel 
-1 subunit (CACNL1A3) account for the majority of cases. Recently, mutations in the gene coding for the skeletal muscle voltage-gated sodium channel subunit (SCN4A) have been reported in a small number of hypoPP families. In order to determine the relative frequency of the CANCL1A3 and SCN4A mutations in a large population of hypoPP patients, and to specify the clinical and pathological features associated with each of them, we searched for mutations in 58 independent hypoPP index cases. We detected the causative mutation in 45 cases: 40 were linked to the CACNL1A3 gene and five to the SCN4A gene. One mutation has not been described before. Some remarkable clinical features were observed in a large hypoPP family carrying an SCN4A mutation: a complete penetrance in men and women, an early age at onset, postcritic myalgias and an increased number and severity of attacks induced by acetazolamide. A muscle biopsy, performed in two members of this family, revealed a peculiar myopathy characterized by tubular aggregates. In contrast, vacuoles were predominant in muscles from hypoPP patients carrying CACNL1A3 mutations. Our findings point to the usefulness of a molecular characterization of hypoPP patients in clinical practice. They also provide new clues for understanding the mechanisms behind functional and structural alterations of the skeletal muscle in hypoPP.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Burtey, D. Sternberg, K. Nguyen, N. Philip, Y. Berland, and B. Dussol Hypokalaemia and dysmorphia, is there a link? NDT Plus, June 1, 2009; 2(3): 222 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Matthews, R. Labrum, M. G. Sweeney, R. Sud, A. Haworth, P. F. Chinnery, G. Meola, S. Schorge, D. M. Kullmann, M. B. Davis, et al. Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis Neurology, May 5, 2009; 72(18): 1544 - 1547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Meola, M G Hanna, and B Fontaine Diagnosis and new treatment in muscle channelopathies J. Neurol. Neurosurg. Psychiatry, April 1, 2009; 80(4): 360 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Jurkat-Rott, M.-A. Weber, M. Fauler, X.-H. Guo, B. D. Holzherr, A. Paczulla, N. Nordsborg, W. Joechle, and F. Lehmann-Horn K+-dependent paradoxical membrane depolarization and Na+ overload, major and reversible contributors to weakness by ion channel leaks PNAS, March 10, 2009; 106(10): 4036 - 4041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Struyk, V. S. Markin, D. Francis, and S. C. Cannon Gating Pore Currents in DIIS4 Mutations of NaV1.4 Associated with Periodic Paralysis: Saturation of Ion Flux and Implications for Disease Pathogenesis J. Gen. Physiol., October 1, 2008; 132(4): 447 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Chabrier, N Monnier, and J Lunardi Early onset of hypokalaemic periodic paralysis caused by a novel mutation of the CACNA1S gene J. Med. Genet., October 1, 2008; 45(10): 686 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Cohen, N. Ilan, M. Gur, W. Stuhmer, D. Gordon, and M. Gurevitz Design of a Specific Activator for Skeletal Muscle Sodium Channels Uncovers Channel Architecture J. Biol. Chem., October 5, 2007; 282(40): 29424 - 29430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Struyk and S. C. Cannon A Na+ Channel Mutation Linked to Hypokalemic Periodic Paralysis Exposes a Proton-selective Gating Pore J. Gen. Physiol., July 1, 2007; 130(1): 11 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. -Y. Ng, S. -H. Lin, C. -Y. Hsu, Y. -Z. Tsai, H. -C. Chen, and C. -T. Lee Hypokalemic paralysis due to Gitelman syndrome: A family study. Neurology, September 26, 2006; 67(6): 1080 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Leipold, A. Hansel, A. Borges, and S. H. Heinemann Subtype Specificity of Scorpion beta-Toxin Tz1 Interaction with Voltage-Gated Sodium Channels Is Determined by the Pore Loop of Domain 3 Mol. Pharmacol., July 1, 2006; 70(1): 340 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Venance, S. C. Cannon, D. Fialho, B. Fontaine, M. G. Hanna, L. J. Ptacek, M. Tristani-Firouzi, R. Tawil, R. C. Griggs, and the CINCH investigators The primary periodic paralyses: diagnosis, pathogenesis and treatment Brain, January 1, 2006; 129(1): 8 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T D Graves and M G Hanna Neurological channelopathies Postgrad. Med. J., January 1, 2005; 81(951): 20 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Vicart, D. Sternberg, E. Fournier, F. Ochsner, P. Laforet, T. Kuntzer, B. Eymard, B. Hainque, and B. Fontaine New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis Neurology, December 14, 2004; 63(11): 2120 - 2127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Venance, K. Jurkat-Rott, F. Lehmann-Horn, and R. Tawil SCN4A-associated hypokalemic periodic paralysis merits a trial of acetazolamide Neurology, November 23, 2004; 63(10): 1977 - 1977. [Full Text] [PDF]
|
|
|
|
|
|
T. M. Miller, M. R. Dias da Silva, H. A. Miller, H. Kwiecinski, J. R. Mendell, R. Tawil, P. McManis, R. C. Griggs, C. Angelini, S. Servidei, et al. Correlating phenotype and genotype in the periodic paralyses Neurology, November 9, 2004; 63(9): 1647 - 1655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Sugiura, N. Makita, L. Li, P. J. Noble, J. Kimura, Y. Kumagai, T. Soeda, and T. Yamamoto Cold induces shifts of voltage dependence in mutant SCN4A, causing hypokalemic periodic paralysis Neurology, October 14, 2003; 61(7): 914 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sternberg, N. Tabti, E. Fournier, B. Hainque, and B. Fontaine Lack of association of the potassium channel-associated peptide MiRP2-R83H variant with periodic paralysis Neurology, September 23, 2003; 61(6): 857 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Thuss-Patience, U. Peters, K. Jurkat-Rott, D. Pink, A. Kretzschmar, B. Dorken, and P. Reichardt Acute Hypokalemic Tetraparesis Induced by Intravenous Methotrexate J. Clin. Oncol., May 1, 2003; 21(9): 1896 - 1897. [Full Text] [PDF]
|
|
|
|
|
|
A. Kuzmenkin, V. Muncan, K. Jurkat-Rott, C. Hang, H. Lerche, F. Lehmann-Horn, and N. Mitrovic Enhanced inactivation and pH sensitivity of Na+ channel mutations causing hypokalaemic periodic paralysis type II Brain, April 1, 2002; 125(4): 835 - 843. [Abstract] [Full Text] [PDF]
|
|